BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
暂无分享,去创建一个
E. Shin | Su‐Hyung Park | J. Noh | J. Song | H. Jeong | Seongju Jeong | M. Jung | Dong-Uk Kim | Sung-Joo Jung
[1] P. Österlund,et al. Neutralizing antibodies to SARS‐CoV‐2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects , 2022, European journal of immunology.
[2] N. Dean,et al. The changing epidemiology of SARS-CoV-2 , 2022, Science.
[3] B. Walker,et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals , 2022, Cell.
[4] S. Bhatt,et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.
[5] J. Dillner,et al. Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study , 2022, The Lancet Infectious Diseases.
[6] L. Poon,et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo , 2022, Nature.
[7] Frances E. Muldoon,et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.
[8] D. Barouch,et al. Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron , 2022, Nature.
[9] A. Sette,et al. T cell responses to SARS-CoV-2 spike cross-recognize Omicron , 2022, Nature.
[10] S. Schrag,et al. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. , 2022, JAMA.
[11] E. Shin,et al. T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant , 2022, Cellular & Molecular Immunology.
[12] A. Sette,et al. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant , 2022, Nature Medicine.
[13] D. Douek,et al. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant , 2022, Cell Reports Medicine.
[14] Christina C. Chang,et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant , 2022, Cell.
[15] S. Mallal,et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron , 2022, Cell.
[16] C. Riou,et al. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose , 2022, The Lancet.
[17] Jordan J. Clark,et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron , 2021, Nature.
[18] T. Ndung’u,et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization , 2021, Nature.
[19] P. Maes,et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization , 2021, Nature.
[20] Liyuan Liu,et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 , 2021, Nature.
[21] P. Schommers,et al. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant , 2021, Nature Medicine.
[22] H. Jäck,et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic , 2021, Cell.
[23] E. Callaway. Heavily mutated Omicron variant puts scientists on alert , 2021, Nature.
[24] I. Pedraza,et al. T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals , 2021, Cellular & Molecular Immunology.
[25] Jerome H. Kim,et al. T cell-oriented strategies for controlling the COVID-19 pandemic , 2021, Nature Reviews Immunology.
[26] J. Sidney,et al. Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19 , 2021, PLoS pathogens.
[27] R. Scheuermann,et al. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals , 2021, Cell Reports Medicine.
[28] M. Koopmans,et al. SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients , 2021, Science Immunology.
[29] E. Shin,et al. SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern , 2021, Signal Transduction and Targeted Therapy.
[30] E. Wherry,et al. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer , 2021, Nature Medicine.
[31] J. Blankson,et al. SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63. , 2021, The Journal of clinical investigation.
[32] Jincun Zhao,et al. Mapping and role of T cell response in SARS-CoV-2–infected mice , 2021, The Journal of experimental medicine.
[33] D. Lauffenburger,et al. Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques , 2020, Nature.
[34] H. Rammensee,et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition , 2020, Nature immunology.
[35] J. Greenbaum,et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.
[36] M. Okano,et al. Cohort Study , 2020, Definitions.
[37] A. Folgori,et al. Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus. , 2012, Gastroenterology.
[38] Pedagógia,et al. Cross Sectional Study , 2019 .
[39] M. Roederer,et al. T-cell quality in memory and protection: implications for vaccine design , 2008, Nature Reviews Immunology.
[40] Mario Roederer,et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses , 2007, The Journal of experimental medicine.
[41] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.